Professor Bill Paxton PhD DIC
Professor Clinical Infection, Microbiology & Immunology
- +44 (0)151 795 9605
- Work email W.A.Paxton@liverpool.ac.uk
Research
Research Interest 1
The main research focus of the lab is the better understanding of the viral and host factors associated with HIV-1 transmission and disease progression. The emphasis being on stuyding the genotypic as well as phenotypic properties of the gp120 envelope protein asscoiated with both of the above. More recently we have studied HIV-1 in the context of co-infection with other pathogens, including TB, Helminthic parasites, HPV and HCV.
Research Grants
Bench Fees for Gufran Yousef A Al Ahmad (201694848)
ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)
February 2023 - September 2024
To develop pseudovirus models for home and personal care application
UNILEVER PLC (UK)
July 2021 - February 2023
CCP - UK
MEDICAL RESEARCH COUNCIL
March 2020 - September 2022
Bench fees for Ashteeaq Talal D Aljehane (201458186)
ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)
October 2021 - September 2022
To research the development of pseudovirus models for use in laboratory models
UNILEVER PLC (UK)
September 2022 - August 2026
Accelerating Research & Development for Advanced Therapies (ARDAT)
BAYER AG (GERMANY), EUROPEAN COMMISSION
November 2020 - October 2025
The exposure of urban rodents to the human COVID-19 virus and the potential for viral recombination
NATURAL ENVIRONMENT RESEARCH COUNCIL
April 2020 - September 2021
Research Support Fees for Abdullateef Abdullah Alshehri
ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)
February 2020 - January 2023
Research Support Fees for Miss Wejdan Oudah M Albawi
ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)
April 2019 - October 2023
European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates.
EUROPEAN COMMISSION
January 2016 - December 2023
Pathogen Co-infection: HIV-1, Tuberculosis, Malaria and hepatitis C virus (PATHCO)
EUROPEAN COMMISSION
October 2013 - October 2017